NCT07336693

Bone Density Change in Postmenopausal Rheumatoid Arthritis

Changes in Bone Mineral Density and the Impact of Therapeutic Approaches in Postmenopausal Patients With Rheumatoid Arthritis

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 82 (actual)
• Sponsor: Istanbul University - Cerrahpasa · Academic / Other
• Sex: Female
• Age: —
• Healthy volunteers: Not accepted

Summary

Rheumatoid arthritis is associated with systemic inflammation-mediated bone loss, leading to an increased risk of osteoporosis and fractures, particularly in postmenopausal patients. Although disease-modifying antirheumatic drugs may help mitigate bone loss, comparative longitudinal data on different treatment strategies remain limited. This study aimed to evaluate changes in bone mineral density over time and assess the impact of conventional synthetic and biologic DMARDs, together with anti-osteoporotic therapy, on bone health.

Conditions

• Rheumatoid Arthritis (RA)
• Osteoporosis

Interventions

Type	Name	Description
DIAGNOSTIC_TEST	Bone Density Test	BMD values were obtained from DXA scans performed at the lumbar spine (L1-L4), femoral neck, and total femur. All DXA measurements were conducted at the Department of Nuclear Medicine using the same device, a Hologic QDR 4500SL (S/N 45624, Bedford, MA), to ensure methodological consistency. Reference values were based on the NHANES III.

Timeline

• Start date: 2025-06-01
• Primary completion: 2025-09-01
• Completion: 2025-12-01
• First posted: 2026-01-13
• Last updated: 2026-01-13

Locations

1 site across 1 country: Turkey (Türkiye)